have be treat with felbamate or vigabatrin within the 6 month prior to screening if a subject have be previously treat with vigabatrin 6 month prior to screening a visual perimetry test perform within 6 month prior to screening must show normal visual field or no worsening of recognized visual field abnormality a compare with prior to vigabatrin treatment 